Review and Analysis of Massively Registered Clinical Trials of COVID-19 using the Text Mining Approach
Journal:
Reviews on Recent Clinical Trials
Volume:
16
Page:
242-257
Author(s):
Swayamprakash Patel*, Ashish Patel, Mruduka Patel, Umang Shah, Mehul Patel, Nilay Solanki and Suchita Patel
Impact of Covid-19 on Mental Health: An Overview
Journal:
Reviews on Recent Clinical Trials
Volume:
16
Page:
227-231
Author(s):
Minal M. Kshirsagar*, Arun S. Dodamani, Girija A. Dodamani, Vrushali R. Khobragade and Rahul N. Deokar
Epidemiological Characteristics of 64 Covid-19 Patients in Errachidia Province (Darâa-Tafilalet region), Morocco: A Retrospective Analysis
Journal:
Reviews on Recent Clinical Trials
Volume:
16
Page:
294-302
Author(s):
Mourad Akdad, Youness Algharrass, Hafid Talha, Abdelaadim Babakhouya, Mohammed Ajebli, Ahlam Ech-cherrate and Mohamed Eddouks*
Potential Inhibition of COVID-19 RNA-dependent RNA Polymerase by Hepatitis C Virus Non-nucleoside Inhibitors: An In-silico Perspective
Journal:
Letters in Drug Design & Discovery
Volume:
18
Page:
429-435
Author(s):
Yee Siew Choong*, Theam Soon Lim, Hanyun Liu, Rubin Jiang, Zimu Cai and Yuan Ge*
Hispidin and Lepidine E: Two Natural Compounds and Folic Acid as Potential Inhibitors of 2019-novel Coronavirus Main Protease (2019- nCoVMpro), Molecular Docking and SAR Study
Journal:
Current Computer-Aided Drug Design
Volume:
17
Page:
469-479
Author(s):
Talia Serseg*, Khedidja Benarous and Mohamed Yousfi
Chitosan: A Promising Protective Component Against SARS-CoV-2 and Influenza Virus
Journal:
Letters in Drug Design & Discovery
Volume:
18
Page:
418-421
Author(s):
Mohammad Reza Rahbar, Hadi Esmaeili Gouvarchin Galeh, Saeed Khalili and Abolfazl Jahangiri*
Do We have the Evidence to Repurpose Levamisole for Treatment of COVID 19?
Journal:
Current Drug Therapy
Volume:
16
Page:
142-147
Author(s):
Keshab Mukhopadhyay, Chanchal Kumar Dalai, Ritesh Singh, Shah Newaz Ahmed* and Kushal Banerjee
Computational Evidences of Phytochemical Mediated Disruption of PLpro Driven Replication of SARS-CoV-2: A Therapeutic Approach against COVID-19
Journal:
Current Pharmaceutical Biotechnology
Volume:
22
Page:
1350-1359
Author(s):
Acharya Balkrishna, Rashmi Mittal and Vedpriya Arya*
Potential Implications of Black Seed and its Principal Constituent Thymoquinone in the Treatment of COVID-19 Patients
Journal:
Current Pharmaceutical Biotechnology
Volume:
22
Page:
1315-1324
Author(s):
Masood Alam Khan* and Hina Younus
Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection?
Journal:
Current Drug Targets
Volume:
22
Page:
1149-1157
Author(s):
Vivek K. Gupta*, Madhan K. Murthy and Shripad Patil